Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Bendroflumethiazide
Drug ID BADD_D00232
Description A thiazide diuretic with actions and uses similar to those of hydrochlorothiazide. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
Indications and Usage For the treatment of high blood pressure and management of edema related to heart failure.
Marketing Status approved
ATC Code C03AA01
DrugBank ID DB00436
KEGG ID D00650
MeSH ID D001539
PubChem ID 2315
TTD Drug ID D02PAH
NDC Product Code 69988-0028; 53747-004
UNII 5Q52X6ICJI
Synonyms Bendroflumethiazide | Bendrofluazide | Benzide | Benzide-M | Benzide M | Berkozide | Urizid | Esberizid | Naturetin | Neo-NaClex | Neo NaClex | Aprinox | Centyl | Pluryl | Naturine
Chemical Information
Molecular Formula C15H14F3N3O4S2
CAS Registry Number 73-48-3
SMILES C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.001--
Agranulocytosis01.02.03.001--Not Available
Anaphylactic reaction24.06.03.006; 10.01.07.001--
Aplastic anaemia01.03.03.002--Not Available
Asthenia08.01.01.001--Not Available
Blood potassium abnormal13.11.01.024--Not Available
Constipation07.02.02.001--
Cutaneous vasculitis24.12.04.008; 23.06.02.001; 10.02.02.003--Not Available
Dermatitis23.03.04.002--Not Available
Dermatitis exfoliative23.03.07.001; 10.01.01.004--
Diabetes mellitus14.06.01.001; 05.06.01.001--Not Available
Diarrhoea07.02.01.001--
Dizziness02.11.04.006; 24.06.02.007; 17.02.05.003--
Drug interaction08.06.03.001--Not Available
Ecchymosis24.07.06.002; 23.06.01.001; 01.01.03.001--Not Available
Glomerulonephritis20.05.01.001; 10.02.01.006--Not Available
Glycosuria20.02.01.005--
Gout15.01.06.001; 14.09.01.001--Not Available
Haemolytic anaemia01.06.03.002--Not Available
Headache17.14.01.001--
Hepatic encephalopathy17.13.01.003; 09.01.03.006--Not Available
Hepatitis09.01.07.004--Not Available
Hyperglycaemia05.06.02.002; 14.06.02.002--
Hypersensitivity vasculitis24.12.04.013; 23.06.02.005; 10.02.02.017; 01.01.04.008--Not Available
Hyperuricaemia14.09.01.003--
Hypokalaemia14.05.03.002--
Hypotension24.06.03.002--
Jaundice23.03.03.030; 09.01.01.004; 01.06.04.004--Not Available
Leukopenia01.02.02.001--Not Available
Metabolic acidosis14.01.01.003--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages